Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03109158
Title NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NanoCarrier Co., Ltd.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.